Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DGNX | Pelham Miles Christian | Director | 17.08.2026 | Verkauf | 1,00 | 1.908.540 | 1.908.540 | Form 4 |
| DGICB | Donegal Mutual Insurance Co | 10% Owner | 17.08.2026 | Kauf | 18,52 | 10.000 | 185.239 | Form 4 |
| DGICB | Bawel David Benjamin | SVP & CHIEF ACCOUNTING OFFICER | 14.08.2026 | J | 19,45 | 53 | 1.031 | Form 4 |
| DGICB | Viozzi Vincent Anthony | Sr. VP & Chief Inv Officer | 14.08.2026 | J | 19,45 | 32 | 622 | Form 4 |
| DGICB | Burke Kevin Gerard | President & Chief Exec Officer | 14.08.2026 | J | 19,45 | 33 | 642 | Form 4 |
| DGICB | Miller Jeffrey Dean | EVP & Chief Financial Officer | 14.08.2026 | J | 19,45 | 417 | 8.111 | Form 4 |
| DGICA | Hoffman Christina Marie | Sr. VP & Chief Risk Officer | 06.08.2026 | Verkauf | 19,67 | 18.000 | 354.060 | Form 4 |
| DGICA | Hoffman Christina Marie | Sr. VP & Chief Risk Officer | 06.08.2026 | Optionsausübung | 14,39 | 18.000 | 259.020 | Form 4 |
| DGICA | Donegal Mutual Insurance Co | 10% Owner | 06.08.2026 | Kauf | 19,67 | 18.000 | 354.060 | Form 4 |
| DGICA | Deas Noland Rone Jr | Senior Vice President | 04.08.2026 | Verkauf | 19,47 | 24.000 | 467.280 | Form 4 |
| DGICA | Deas Noland Rone Jr | Senior Vice President | 04.08.2026 | Optionsausübung | 15,76 | 12.000 | 189.120 | Form 4 |
| DGICA | Deas Noland Rone Jr | Senior Vice President | 04.08.2026 | Optionsausübung | 13,87 | 8.000 | 110.960 | Form 4 |
| DGICA | Deas Noland Rone Jr | Senior Vice President | 04.08.2026 | Optionsausübung | 14,09 | 4.000 | 56.360 | Form 4 |
| DGICA | King David Charles | Director | 04.08.2026 | Verkauf | 19,33 | 9.000 | 173.970 | Form 4 |
| DGICA | King David Charles | Director | 04.08.2026 | Optionsausübung | 14,09 | 4.500 | 63.405 | Form 4 |
| DGICA | Bixenman Dennis Joseph | Director | 04.08.2026 | Verkauf | 19,26 | 11.250 | 216.675 | Form 4 |
| DGICA | Bixenman Dennis Joseph | Director | 04.08.2026 | Optionsausübung | 13,87 | 4.500 | 62.415 | Form 4 |
| DGICA | Bixenman Dennis Joseph | Director | 04.08.2026 | Optionsausübung | 14,39 | 2.250 | 32.378 | Form 4 |
| DGX | Delaney Mark E | SVP & Chief Commercial Officer | 28.07.2026 | Verkauf | 235,18 | 1.600 | 376.288 | Form 4 |
| DGX | Kuppusamy Karthik | SVP, Clinical Solutions | 22.07.2026 | L | 206,81 | 37 | 7.652 | Form 4 |
| DGX | Carter Robert B | Director | 22.07.2026 | L | 206,80 | 11 | 2.275 | Form 4 |
| DGX | Gregg Vicky B | Director | 22.07.2026 | Zuteilung | 206,81 | 72 | 14.890 | Form 4 |
| DGX | Plewman Patrick | SVP for Diagnostic Services | 22.07.2026 | L | 206,81 | 46 | 9.513 | Form 4 |
| DGX | Main Timothy L | Director | 22.07.2026 | L | 206,81 | 21 | 4.343 | Form 4 |
| DGX | Samad Sam | Executive Vice President & CFO | 22.07.2026 | Zuteilung | 206,81 | 102 | 21.094 | Form 4 |
| DGX | Lassiter Wright III | Director | 22.07.2026 | L | 206,81 | 6 | 1.241 | Form 4 |
| DGX | Delaney Mark E | SVP & Chief Commercial Officer | 22.07.2026 | L | 206,81 | 34 | 7.031 | Form 4 |
| DGICB | Pandey Sanjay | Sr. VP & Chief Info Officer | 23.06.2026 | I | 17,75 | 28.829 | 511.715 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).